EDGEMOND JAMES

PrivateCIK: 1636178
Location

SILVER SPRING, MD

EDGEMOND JAMES (CFO AND TREASURER) sold 34.6% of their position (10K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $5.72M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 8 sales
InsiderEDGEMOND JAMESCIK 1636178
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Officer· CFO AND TREASURER
Since Mar 2023
-10K
Net shares
Net seller
$5.72M
Total sold
8
Open market trades
0B · 8S
10
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions9

Common Stock

Direct
S · Sale

Shares

364.00

Price / share

$575.85

Trade value

$209.61K

% of position

1.9%
4/22/2026
19.36K19K

Common Stock

Direct
M · Option Exercise

Shares

+10K

Price / share

$135.42

Trade value

$1.35M

% of position

53.0%
4/23/2026
18.88K28.88K

Common Stock

Direct
S · Sale

Shares

280.00

Price / share

$569.63

Trade value

$159.50K

% of position

1.0%
4/23/2026
28.88K28.60K

Common Stock

Direct
S · Sale

Shares

1.08K

Price / share

$570.82

Trade value

$615.91K

% of position

3.8%
4/23/2026
28.60K27.52K

Common Stock

Direct
S · Sale

Shares

3.33K

Price / share

$571.64

Trade value

$1.90M

% of position

12.1%
4/23/2026
27.52K24.19K

Common Stock

Direct
S · Sale

Shares

3.98K

Price / share

$572.66

Trade value

$2.28M

% of position

16.4%
4/23/2026
24.19K20.22K

Common Stock

Direct
S · Sale

Shares

321.00

Price / share

$573.51

Trade value

$184.10K

% of position

1.6%
4/23/2026
20.22K19.89K

Common Stock

Direct
S · Sale

Shares

535.00

Price / share

$574.79

Trade value

$307.51K

% of position

2.7%
4/23/2026
19.89K19.36K

Common Stock

Direct
S · Sale

Shares

120.00

Price / share

$576.62

Trade value

$69.19K

% of position

0.6%
4/23/2026
19K18.88K
Total

Net shares

+0.00

Net value

-$4.37M

Derivative Transactions1

Stock Option

Direct
M · Option Exercise
Converts to

Common Stock

10K shares

Shares

10K

Strike price

135.42

Held after

62.50K

Exercisable

4/23/2026
EDGEMOND JAMES — Insider Transaction (Form 4) Filed Apr 24, 2026 | Finecho